Literature DB >> 22039999

Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A/H1N1) infection in A549 bronchial epithelial cells.

Thuy Thi Bich Phung1, Ryuichi Sugamata, Kazuko Uno, Yasuaki Aratani, Keiko Ozato, Shoji Kawachi, Liem Thanh Nguyen, Toshinori Nakayama, Kazuo Suzuki.   

Abstract

Influenza virus infection causes severe respiratory disease such as that due to avian influenza (H5N1). Influenza A viruses proliferate in human epithelial cells, which produce inflammatory cytokines/chemokines as a "cytokine storm" attenuated with the viral nonstructural protein 1 (NS1). Cytokine/chemokine production in A549 epithelial cells infected with influenza A/H1N1 virus (PR-8) or nonstructural protein 1 (NS1) plasmid was examined in vitro. Because tumor necrosis factor-α (TNF-α) and regulated upon activation normal T-cell expressed and secreted (RANTES) are predominantly produced from cells infected with PR-8 virus, the effects of mRNA knockdown of these cytokines were investigated. Small interfering (si)TNF-α down-regulated RANTES expression and secretion of RANTES, interleukin (IL)-8, and monocyte chemotactic protein-1 (MCP-1). In addition, siRANTES suppressed interferon (IFN)-γ expression and secretion of RANTES, IL-8, and MCP-1, suggesting that TNF-α stimulates production of RANTES, IL-8, MCP-1, and IFN-γ, and RANTES also increased IL-8, MCP-1, and IFN-γ. Furthermore, administration of TNF-α promoted increased secretion of RANTES, IL-8, and MCP-1. Administration of RANTES enhanced IL-6, IL-8, and MCP-1 production without PR-8 infection. These results strongly suggest that, as an initial step, TNF-α regulates RANTES production, followed by increase of IL-6, IL-8, and MCP-1 and IFNs concentrations. At a later stage, cells transfected with viral NS1 plasmid showed production of a large amount of IL-8 and MCP-1 in the presence of the H(2)O(2)-myeloperoxidse (MPO) system, suggesting that NS1 of PR-8 may induce a "cytokine storm" from epithelial cells in the presence of an H(2)O(2)-MPO system.
© 2011 The Societies and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039999      PMCID: PMC4158925          DOI: 10.1111/j.1348-0421.2011.00396.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  35 in total

Review 1.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.

Authors:  Robert M Krug; Weiming Yuan; Diana L Noah; Anita Ghate Latham
Journal:  Virology       Date:  2003-05-10       Impact factor: 3.616

Review 2.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

3.  Swine dust induces cytokine secretion from human epithelial cells and alveolar macrophages.

Authors:  Z Wang; P Malmberg; A Ek; K Larsson; L Palmberg
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

4.  Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling.

Authors:  Benjamin G Hale; David Jackson; Yun-Hsiang Chen; Robert A Lamb; Richard E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

5.  Expression of RANTES by normal airway epithelial cells after influenza virus A infection.

Authors:  S Matsukura; F Kokubu; H Kubo; T Tomita; H Tokunaga; M Kadokura; T Yamamoto; Y Kuroiwa; T Ohno; H Suzaki; M Adachi
Journal:  Am J Respir Cell Mol Biol       Date:  1998-02       Impact factor: 6.914

6.  Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production.

Authors:  Astrid Haegens; Peter Heeringa; Robert Jan van Suylen; Chad Steele; Yasuaki Aratani; Robert J J O'Donoghue; Steven E Mutsaers; Brooke T Mossman; Emiel F M Wouters; Juanita H J Vernooy
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust.

Authors:  L Palmberg; B M Larsson; P Malmberg; K Larsson
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

8.  Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice.

Authors:  Akiko Ishida-Okawara; Toshiko Ito-Ihara; Eri Muso; Takahiko Ono; Kan Saiga; Kyuichi Nemoto; Kazuo Suzuki
Journal:  Nephrol Dial Transplant       Date:  2004-05-18       Impact factor: 5.992

9.  siRNA for Influenza Therapy.

Authors:  Sailen Barik
Journal:  Viruses       Date:  2010-07-09       Impact factor: 5.818

10.  Re-emergence of fatal human influenza A subtype H5N1 disease.

Authors:  J S M Peiris; W C Yu; C W Leung; C Y Cheung; W F Ng; J M Nicholls; T K Ng; K H Chan; S T Lai; W L Lim; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  12 in total

1.  Antiviral effects and mechanisms of Yinhuapinggan granule against H1N1 influenza virus infection in RAW264.7 cells.

Authors:  Hai-Xia Du; Hui-Fen Zhou; Hao-Fang Wan; Jie-Hong Yang; Yi-Yu Lu; Yu He; Hai-Tong Wan
Journal:  Inflammopharmacology       Date:  2018-03-03       Impact factor: 4.473

2.  Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells.

Authors:  Drirh Khare; Nachiket M Godbole; Shailesh D Pawar; Vishwa Mohan; Gaurav Pandey; Sushil Gupta; Deepak Kumar; Tapan N Dhole; Madan M Godbole
Journal:  Eur J Nutr       Date:  2012-09-27       Impact factor: 5.614

3.  An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice.

Authors:  Yongzhen Zhao; Lingcai Zhao; Yingfei Li; Qingzheng Liu; Lulu Deng; Yuanlu Lu; Xiaoting Zhang; Shengmin Li; Jinying Ge; Zhigao Bu; Jihui Ping
Journal:  Vet Microbiol       Date:  2022-06-09       Impact factor: 3.246

4.  Soluble polysialylated NCAM: a novel player of the innate immune system in the lung.

Authors:  Christina Ulm; Mona Saffarzadeh; Poornima Mahavadi; Sandra Müller; Gerlinde Prem; Farhan Saboor; Peter Simon; Ralf Middendorff; Hildegard Geyer; Ingrid Henneke; Nils Bayer; Susanne Rinné; Thomas Lütteke; Eva Böttcher-Friebertshäuser; Rita Gerardy-Schahn; David Schwarzer; Martina Mühlenhoff; Klaus T Preissner; Andreas Günther; Rudolf Geyer; Sebastian P Galuska
Journal:  Cell Mol Life Sci       Date:  2013-04-26       Impact factor: 9.261

Review 5.  Virus-specific factors associated with zoonotic and pandemic potential.

Authors:  Aurora Romero-Tejeda; Ilaria Capua
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

6.  Redox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress.

Authors:  Paola Checconi; Sonia Salzano; Lucas Bowler; Lisa Mullen; Manuela Mengozzi; Eva-Maria Hanschmann; Christopher Horst Lillig; Rossella Sgarbanti; Simona Panella; Lucia Nencioni; Anna Teresa Palamara; Pietro Ghezzi
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

7.  IL-1β is a key cytokine that induces trypsin upregulation in the influenza virus-cytokine-trypsin cycle.

Authors:  I L Indalao; T Sawabuchi; E Takahashi; H Kido
Journal:  Arch Virol       Date:  2016-10-06       Impact factor: 2.574

8.  Influenza A Viruses Replicate Productively in Mouse Mastocytoma Cells (P815) and Trigger Pro-inflammatory Cytokine and Chemokine Production through TLR3 Signaling Pathway.

Authors:  Di Meng; Caiyun Huo; Ming Wang; Jin Xiao; Bo Liu; Tangting Wei; Hong Dong; Guozhong Zhang; Yanxin Hu; Lunquan Sun
Journal:  Front Microbiol       Date:  2017-01-12       Impact factor: 5.640

9.  Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case.

Authors:  Ariel Rodriguez; Ana Falcon; Maria Teresa Cuevas; Francisco Pozo; Susana Guerra; Blanca García-Barreno; Pamela Martinez-Orellana; Pilar Pérez-Breña; Maria Montoya; Jose Antonio Melero; Manuel Pizarro; Juan Ortin; Inmaculada Casas; Amelia Nieto
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

10.  Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.

Authors:  Marie-Claude Bourgeois-Daigneault; Dominic Guy Roy; Theresa Falls; Kwame Twumasi-Boateng; Lauren Elizabeth St-Germain; Monique Marguerie; Vanessa Garcia; Mohammed Selman; Victoria Ann Jennings; Jessica Pettigrew; Sally Amos; Jean-Simon Diallo; Brad Nelson; John Cameron Bell
Journal:  Mol Ther Oncolytics       Date:  2016-02-17       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.